MedTrace Logo

Anti-inflammatory Agents and Cholesterol Metabolism

NCT01279395 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2019-08-16

No results posted yet for this study

Summary

We hypothesize that administration of anti-inflammatory medications such as celecoxib, naprosyn and diclofenac will cause changes in the blood plasma and white blood cells of patients such that they will be less able to efficiently process cholesterol.

Conditions

Sponsors & Collaborators

  • Winthrop University Hospital

    lead OTHER

Principal Investigators

  • Allison B Reiss, MD · Winthrop University Hospital

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2018-01-18
Completion
2018-01-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01279395 on ClinicalTrials.gov